Neurosteroids as endogenous regulators of seizure susceptibility and use in the treatment of epilepsy

16Citations
Citations of this article
64Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Neurosteroids such as allopregnanolone are positive allosteric modulators of γ-aminobutyric acid (GABA)A receptors with powerful antiseizure activity in diverse animal models. Neurosteroids may be endogenous regulators of seizure susceptibility, for example, in catamenial epilepsy. Clinical trials with the synthetic neurosteroid analog ganaxolone in the treatment of refractory partial seizures and infantile spasms have been encouraging. Neurosteroids and analogs such as ganaxolone show promise in the treatment of diverse forms of epilepsy. For an expanded treatment of this topic see Jasper's basic mechanisms of the epilepsies. 4th ed. (Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, eds) published by Oxford University Press (available on the National Library of Medicine Bookshelf [NCBI] at). © 2010 International League Against Epilepsy.

Cite

CITATION STYLE

APA

Reddy, D. S., & Rogawski, M. A. (2010). Neurosteroids as endogenous regulators of seizure susceptibility and use in the treatment of epilepsy. Epilepsia, 51(SUPPL. 5), 84. https://doi.org/10.1111/j.1528-1167.2010.02870.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free